A new nomogram to predict pathologic outcome following radical prostatectomy

OBJECTIVE: To develop a preoperative nomogram to predict pathologic outcome in patients submitted to radical prostatectomy for clinical localized prostate cancer. MATERIALS AND METHODS: Nine hundred and sixty patients with clinical stage T1 and T2 prostate cancer were evaluated following radical prostatectomy, and 898 were included in the study. Following a multivariate analysis, nomograms were developed incorporating serum PSA, biopsy Gleason score, and percentage of positive biopsy cores in order to predict the risks of extraprostatic tumor extension, and seminal vesicle involvement. RESULTS: In univariate analysis there was a significant association between percentage of positive biopsy cores (p < 0.001), serum PSA (p = 0.001) and biopsy Gleason score (p < 0.001) with extraprostatic tumor extension. A similar pathologic outcome was seen among tumors with Gleason score 7, and Gleason score 8 to 10. In multivariate analysis, the 3 preoperative variables showed independent significance to predict tumor extension. This allowed the development of nomogram-1 (using Gleason scores in 3 categories - 2 to 6, 7 and 8 to 10) and nomogram-2 (using Gleason scores in 2 categories - 2 to 6 and 7 to 10) to predict disease extension based on these 3 parameters. In the validation analysis, 87% and 91.1% of the time the nomograms-1 and 2, correctly predicted the probability of a pathological stage to within 10% respectively. CONCLUSION: Incorporating percent of positive biopsy cores to a nomogram that includes preoperative serum PSA and biopsy Gleason score, can accurately predict the presence of extraprostatic disease extension in patients with clinical localized prostate cancer.

Saved in:
Bibliographic Details
Main Authors: Crippa,Alexandre, Srougi,Miguel, Dall’Oglio,Marcos F., Antunes,Alberto A., Leite,Katia R., Nesrallah,Luciano J., Ortiz,Valdemar
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Urologia 2006
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382006000200005
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1677-55382006000200005
record_format ojs
spelling oai:scielo:S1677-553820060002000052006-06-08A new nomogram to predict pathologic outcome following radical prostatectomyCrippa,AlexandreSrougi,MiguelDall’Oglio,Marcos F.Antunes,Alberto A.Leite,Katia R.Nesrallah,Luciano J.Ortiz,Valdemar prostatic neoplasms neoplasm staging nomograms prostate-specific antigen needle biopsy OBJECTIVE: To develop a preoperative nomogram to predict pathologic outcome in patients submitted to radical prostatectomy for clinical localized prostate cancer. MATERIALS AND METHODS: Nine hundred and sixty patients with clinical stage T1 and T2 prostate cancer were evaluated following radical prostatectomy, and 898 were included in the study. Following a multivariate analysis, nomograms were developed incorporating serum PSA, biopsy Gleason score, and percentage of positive biopsy cores in order to predict the risks of extraprostatic tumor extension, and seminal vesicle involvement. RESULTS: In univariate analysis there was a significant association between percentage of positive biopsy cores (p < 0.001), serum PSA (p = 0.001) and biopsy Gleason score (p < 0.001) with extraprostatic tumor extension. A similar pathologic outcome was seen among tumors with Gleason score 7, and Gleason score 8 to 10. In multivariate analysis, the 3 preoperative variables showed independent significance to predict tumor extension. This allowed the development of nomogram-1 (using Gleason scores in 3 categories - 2 to 6, 7 and 8 to 10) and nomogram-2 (using Gleason scores in 2 categories - 2 to 6 and 7 to 10) to predict disease extension based on these 3 parameters. In the validation analysis, 87% and 91.1% of the time the nomograms-1 and 2, correctly predicted the probability of a pathological stage to within 10% respectively. CONCLUSION: Incorporating percent of positive biopsy cores to a nomogram that includes preoperative serum PSA and biopsy Gleason score, can accurately predict the presence of extraprostatic disease extension in patients with clinical localized prostate cancer.info:eu-repo/semantics/openAccessSociedade Brasileira de UrologiaInternational braz j urol v.32 n.2 20062006-04-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382006000200005en10.1590/S1677-55382006000200005
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Crippa,Alexandre
Srougi,Miguel
Dall’Oglio,Marcos F.
Antunes,Alberto A.
Leite,Katia R.
Nesrallah,Luciano J.
Ortiz,Valdemar
spellingShingle Crippa,Alexandre
Srougi,Miguel
Dall’Oglio,Marcos F.
Antunes,Alberto A.
Leite,Katia R.
Nesrallah,Luciano J.
Ortiz,Valdemar
A new nomogram to predict pathologic outcome following radical prostatectomy
author_facet Crippa,Alexandre
Srougi,Miguel
Dall’Oglio,Marcos F.
Antunes,Alberto A.
Leite,Katia R.
Nesrallah,Luciano J.
Ortiz,Valdemar
author_sort Crippa,Alexandre
title A new nomogram to predict pathologic outcome following radical prostatectomy
title_short A new nomogram to predict pathologic outcome following radical prostatectomy
title_full A new nomogram to predict pathologic outcome following radical prostatectomy
title_fullStr A new nomogram to predict pathologic outcome following radical prostatectomy
title_full_unstemmed A new nomogram to predict pathologic outcome following radical prostatectomy
title_sort new nomogram to predict pathologic outcome following radical prostatectomy
description OBJECTIVE: To develop a preoperative nomogram to predict pathologic outcome in patients submitted to radical prostatectomy for clinical localized prostate cancer. MATERIALS AND METHODS: Nine hundred and sixty patients with clinical stage T1 and T2 prostate cancer were evaluated following radical prostatectomy, and 898 were included in the study. Following a multivariate analysis, nomograms were developed incorporating serum PSA, biopsy Gleason score, and percentage of positive biopsy cores in order to predict the risks of extraprostatic tumor extension, and seminal vesicle involvement. RESULTS: In univariate analysis there was a significant association between percentage of positive biopsy cores (p < 0.001), serum PSA (p = 0.001) and biopsy Gleason score (p < 0.001) with extraprostatic tumor extension. A similar pathologic outcome was seen among tumors with Gleason score 7, and Gleason score 8 to 10. In multivariate analysis, the 3 preoperative variables showed independent significance to predict tumor extension. This allowed the development of nomogram-1 (using Gleason scores in 3 categories - 2 to 6, 7 and 8 to 10) and nomogram-2 (using Gleason scores in 2 categories - 2 to 6 and 7 to 10) to predict disease extension based on these 3 parameters. In the validation analysis, 87% and 91.1% of the time the nomograms-1 and 2, correctly predicted the probability of a pathological stage to within 10% respectively. CONCLUSION: Incorporating percent of positive biopsy cores to a nomogram that includes preoperative serum PSA and biopsy Gleason score, can accurately predict the presence of extraprostatic disease extension in patients with clinical localized prostate cancer.
publisher Sociedade Brasileira de Urologia
publishDate 2006
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382006000200005
work_keys_str_mv AT crippaalexandre anewnomogramtopredictpathologicoutcomefollowingradicalprostatectomy
AT srougimiguel anewnomogramtopredictpathologicoutcomefollowingradicalprostatectomy
AT dallogliomarcosf anewnomogramtopredictpathologicoutcomefollowingradicalprostatectomy
AT antunesalbertoa anewnomogramtopredictpathologicoutcomefollowingradicalprostatectomy
AT leitekatiar anewnomogramtopredictpathologicoutcomefollowingradicalprostatectomy
AT nesrallahlucianoj anewnomogramtopredictpathologicoutcomefollowingradicalprostatectomy
AT ortizvaldemar anewnomogramtopredictpathologicoutcomefollowingradicalprostatectomy
AT crippaalexandre newnomogramtopredictpathologicoutcomefollowingradicalprostatectomy
AT srougimiguel newnomogramtopredictpathologicoutcomefollowingradicalprostatectomy
AT dallogliomarcosf newnomogramtopredictpathologicoutcomefollowingradicalprostatectomy
AT antunesalbertoa newnomogramtopredictpathologicoutcomefollowingradicalprostatectomy
AT leitekatiar newnomogramtopredictpathologicoutcomefollowingradicalprostatectomy
AT nesrallahlucianoj newnomogramtopredictpathologicoutcomefollowingradicalprostatectomy
AT ortizvaldemar newnomogramtopredictpathologicoutcomefollowingradicalprostatectomy
_version_ 1756427975292616704